F. M. Nagengast

1.3k total citations · 1 hit paper
14 papers, 929 citations indexed

About

F. M. Nagengast is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, F. M. Nagengast has authored 14 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in F. M. Nagengast's work include Genetic factors in colorectal cancer (7 papers), Colorectal Cancer Treatments and Studies (4 papers) and Colorectal Cancer Screening and Detection (3 papers). F. M. Nagengast is often cited by papers focused on Genetic factors in colorectal cancer (7 papers), Colorectal Cancer Treatments and Studies (4 papers) and Colorectal Cancer Screening and Detection (3 papers). F. M. Nagengast collaborates with scholars based in Netherlands, Austria and Germany. F. M. Nagengast's co-authors include Hans F. A. Vasen, G Griffioen, B. G. Taal, JT Wijnen, Liliana Varesco, Lucio Bertario, Julia Mohr, Riccardo Fodde, PM Khan and JH Kleibeuker and has published in prestigious journals such as Gastroenterology, Cancer and Gut.

In The Last Decade

F. M. Nagengast

14 papers receiving 903 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis

1996 592 citations Hans F. A. Vasen, JT Wijnen et al. Gastroenterology profile →

Peers

Countries citing papers authored by F. M. Nagengast

Since Specialization

Citations

This map shows the geographic impact of F. M. Nagengast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. M. Nagengast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. M. Nagengast more than expected).

Fields of papers citing papers by F. M. Nagengast

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. M. Nagengast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. M. Nagengast. The network helps show where F. M. Nagengast may publish in the future.

Co-authorship network of co-authors of F. M. Nagengast

This figure shows the co-authorship network connecting the top 25 collaborators of F. M. Nagengast. A scholar is included among the top collaborators of F. M. Nagengast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. M. Nagengast. F. M. Nagengast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Genetic Polymorphism in UDP-Glucuronosyltransferase 2B7 and Colorectal Cancer Risk 2009 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·Elise M.J. van der Logt, René H. M. te Morsche, (unknown), H.M.J. Roelofs, Martin Metz, (unknown), F. M. Nagengast, Wilbert H.M. Peters	9
2	Optimizing the detection of hereditary non-polyposis colorectal cancer: An update 2006 ·Scandinavian Journal of Gastroenterology ·(unknown), (unknown), F. M. Nagengast, E. M. Adang, J. Han van Krieken, Nicoline Hoogerbrugge	2
3	Glutathione S-transferase phenotypes in relation to genetic variation and fruit and vegetable consumption in an endoscopy-based population 2006 ·Carcinogenesis ·Mariken Tijhuis, M.H.P.W. Visker, J.M.M.J.G. Aarts, W.H.M. Peters, H.M.J. Roelofs, (unknown), Ivonne M.C.M. Rietjens, (unknown), F. M. Nagengast, F.J. Kok, Ellen Kampman	9
4	[Liver abscesses as a complication of Crohn's disease]. 2005 ·PubMed ·(unknown), Joost P.H. Drenth, F. M. Nagengast	2
5	Current clinical selection strategies for identification of hereditary non‐polyposis colorectal cancer families are inadequate: a meta‐analysis 2004 ·Clinical Genetics ·Wietske Kievit, (unknown), (unknown), (unknown), F. M. Nagengast, (unknown), Nicoline Hoogerbrugge	55
6	Cost effectiveness of a new strategy to identify HNPCC patients 2004 ·Gut ·Wietske Kievit, (unknown), E. M. Adang, Johan L. Severens, J H Kleibeuker, Rolf H. Sijmons, Theo J. M. Ruers, F. M. Nagengast, Hans F. A. Vasen, J. Han van Krieken, Marjolijn J. L. Ligtenberg, Nicoline Hoogerbrugge	69
7	Colonic glutathione and glutathione S-transferase detoxification capacity is lower in patients at risk for colon cancer compared to healthy volunteers 2000 ·Gastroenterology ·(unknown), (unknown), (unknown), F. M. Nagengast	2
8	WHO Consensus statement on the role of nutrition in colorectal cancer* 1999 ·European Journal of Cancer Prevention ·W Scheppach, S Bingham, M.–C. Boutron–Ruault, Maria Gerhardsson de Verdier, Vı́ctor Moreno, F. M. Nagengast, Ram Reifen, Elio Ríboli, Helmut K. Seitz, J Wahrendorf, H. Kasper	69
9	Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis (vol 110, pg 1020, 1996) 1996 ·Gastroenterology ·Hans F. A. Vasen, JT Wijnen, Fred H. Menko, Jan H. Kleibeuker, B. G. Taal, (unknown), F. M. Nagengast, (unknown), Lucio Bertario, Liliana Varesco, Marie Luise Bisgaard, Julia Mohr, Riccardo Fodde, P. Meera Khan	17
10	Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis breakdown → 1996 ·Gastroenterology ·Hans F. A. Vasen, JT Wijnen, (unknown), JH Kleibeuker, B. G. Taal, G Griffioen, F. M. Nagengast, (unknown), Lucio Bertario, Liliana Varesco, (unknown), Julia Mohr, Riccardo Fodde, PM Khan	592
11	Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis 1995 ·British Journal of Cancer ·Cornelis F.M. Sier, H J Vloedgraven, G Griffioen, S Ganesh, F. M. Nagengast, (unknown), H. W. Verspaget	19
12	Effects of consumption of Brussels sprouts on intestinal and lymphocytic glutathione -transferases in humans 1995 ·The Netherlands Journal of Medicine ·(unknown), F. M. Nagengast, (unknown), (unknown), Hans Verhagen, (unknown), Wilma Peters	2
13	Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue 1992 ·British Journal of Cancer ·(unknown), (unknown), Th. Wobbes, L.V.A.M. Beex, F. M. Nagengast, Th. J. Benraad	32
14	Evaluation of seven tumor markers (CA 50, CA 19-9, CA 19-9 TruQuant, CA 72-4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma 1992 ·Cancer ·Theo Wobbes, Chris M.G. Thomas, M F Segers, F. M. Nagengast	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact